Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Zepp Health (ZEPP) Gross Margin (2016 - 2025)

Zepp Health has reported Gross Margin over the past 10 years, most recently at 40.41% for Q4 2025.

  • For Q4 2025, Gross Margin rose 358.0% year-over-year to 40.41%; the TTM value through Dec 2025 reached 38.31%, down 15.0%, while the annual FY2025 figure was 38.31%, 15.0% down from the prior year.
  • Gross Margin for Q4 2025 was 40.41% at Zepp Health, up from 38.16% in the prior quarter.
  • Over five years, Gross Margin peaked at 40.61% in Q3 2024 and troughed at 15.94% in Q1 2023.
  • A 5-year average of 28.74% and a median of 28.2% in 2021 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: crashed -417bps in 2023 and later surged 2085bps in 2024.
  • Year by year, Gross Margin stood at 19.3% in 2021, then rose by 7bps to 20.7% in 2022, then skyrocketed by 68bps to 34.74% in 2023, then rose by 6bps to 36.83% in 2024, then rose by 10bps to 40.41% in 2025.
  • Business Quant data shows Gross Margin for ZEPP at 40.41% in Q4 2025, 38.16% in Q3 2025, and 36.18% in Q2 2025.